University Health Network

The initiatives are being funded with C$24 million over two years and will focus on acute leukemia, immuno-oncology, and brain, ovarian, and pancreatic cancer.

Researchers from the University Health Network in Toronto, the Mayo Clinic, Ohio State University, and University of Miami School of Medicine are among the early-access customers who have been using the product ahead of its commercial launch this week.

Thermo has expanded its collaboration with university partners, including George Mason's Lance Liotta and Emanuel Petricoin, to verify and validate protein biomarkers for cancer and other diseases.

The firm reported no revenues, but it managed to cut its net loss as it prepares to launch its LungExpress Dx product in the US later this year.

Med BioGene's CEO said the company is on track to launch its LungExpress assay in the second half of this year and will likely open a US office to support the test, which will initially be offered in a CLIA-compliant partner lab.

The expanded deal will provide Med Biogene with additional markers for its LungExpress Dx test.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.